Top compounds associated with response to LMNTD2


Feature Type Standardized
Nominal ANOVA
mRNA Gefitinib CTRPv2 pan-cancer AAC 0.014 0.7
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.019 0.7
mRNA ZG-10 GDSC1000 pan-cancer AAC 0.018 0.7
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BRD-K34485477 CTRPv2 pan-cancer AAC -0.03 0.7
mRNA HC-067047 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA OSI-930 CTRPv2 pan-cancer AAC -0.014 0.7
mRNA narciclasine CTRPv2 pan-cancer AAC 0.012 0.7
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.013 0.7
Download CSV